CME Group Inc (NASDAQ:CME) Director Martin J. Gepsman Sells 2,500 Shares

Share on StockTwits

CME Group Inc (NASDAQ:CME) Director Martin J. Gepsman sold 2,500 shares of the firm’s stock in a transaction dated Thursday, June 6th. The shares were sold at an average price of $201.21, for a total transaction of $503,025.00. Following the transaction, the director now directly owns 35,299 shares in the company, valued at $7,102,511.79. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Shares of NASDAQ:CME opened at $198.88 on Thursday. The company has a market cap of $70.96 billion, a P/E ratio of 30.20, a PEG ratio of 4.57 and a beta of 0.24. CME Group Inc has a 12 month low of $158.35 and a 12 month high of $204.56. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.04 and a quick ratio of 1.04.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, May 1st. The financial services provider reported $1.62 EPS for the quarter, beating the consensus estimate of $1.60 by $0.02. The company had revenue of $1.18 billion during the quarter, compared to analysts’ expectations of $1.19 billion. CME Group had a net margin of 42.47% and a return on equity of 9.29%. CME Group’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.86 earnings per share. As a group, equities research analysts anticipate that CME Group Inc will post 6.59 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Monday, June 10th will be paid a dividend of $0.75 per share. The ex-dividend date is Friday, June 7th. This represents a $3.00 annualized dividend and a yield of 1.51%. CME Group’s dividend payout ratio is currently 43.99%.

A number of large investors have recently modified their holdings of CME. Berman Capital Advisors LLC lifted its position in CME Group by 23.9% during the first quarter. Berman Capital Advisors LLC now owns 342 shares of the financial services provider’s stock valued at $56,000 after purchasing an additional 66 shares during the last quarter. Dubuque Bank & Trust Co. lifted its position in CME Group by 83.1% during the first quarter. Dubuque Bank & Trust Co. now owns 152 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 69 shares during the last quarter. Front Barnett Associates LLC lifted its position in CME Group by 5.4% during the fourth quarter. Front Barnett Associates LLC now owns 1,433 shares of the financial services provider’s stock valued at $267,000 after purchasing an additional 73 shares during the last quarter. Van Hulzen Asset Management LLC lifted its position in CME Group by 3.9% during the fourth quarter. Van Hulzen Asset Management LLC now owns 2,012 shares of the financial services provider’s stock valued at $378,000 after purchasing an additional 76 shares during the last quarter. Finally, ETF Managers Group LLC lifted its position in CME Group by 9.5% during the first quarter. ETF Managers Group LLC now owns 898 shares of the financial services provider’s stock valued at $148,000 after purchasing an additional 78 shares during the last quarter. 84.76% of the stock is owned by institutional investors.

A number of analysts recently issued reports on the stock. UBS Group raised their price objective on shares of CME Group from $175.00 to $190.00 and gave the stock a “neutral” rating in a report on Wednesday, June 5th. Zacks Investment Research downgraded shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 price objective for the company. in a report on Monday, May 27th. Citigroup set a $205.00 price objective on shares of CME Group and gave the stock a “buy” rating in a report on Friday, February 15th. BidaskClub upgraded shares of CME Group from a “strong sell” rating to a “sell” rating in a report on Wednesday, April 3rd. Finally, JPMorgan Chase & Co. assumed coverage on shares of CME Group in a report on Friday, February 15th. They set an “underweight” rating and a $164.00 price objective for the company. Three research analysts have rated the stock with a sell rating, six have issued a hold rating and eight have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $188.87.

COPYRIGHT VIOLATION NOTICE: This article was published by Macon Daily and is owned by of Macon Daily. If you are reading this article on another website, it was stolen and reposted in violation of international trademark and copyright laws. The correct version of this article can be accessed at https://macondaily.com/2019/06/13/cme-group-inc-nasdaqcme-director-martin-j-gepsman-sells-2500-shares.html.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Read More: Resistance Level

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.